Fig 1.
Etiologic Spectrum of three different Peritonitis Episodes over 32 years.
Distribution of organisms in period 1 (1979–1992), period 2 (1993–2003) and period 3 (2004–2014); all variables are expressed as percentage; Abbreviation: MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; CNS, coagulase-negative staphylococci; MRSE, methicillin-resistant Staphylococcus epidermidis.
Table 1.
Etiologic Spectrum of three different Peritonitis Episodes over 32 years.
Table 2.
Gram-positive organisms causing Peritoneal Dialysis-Related Peritonitis and their In Vitro Susceptibility Rates over 32 years.
Table 3.
Gram-negative organisms causing Peritoneal Dialysis-Related Peritonitis and their In Vitro Susceptibility Rates over 32 years.
Fig 2.
In vitro susceptibility to empirical intraperitoneal treatment.
A. Gram-positive organisms; B. Gram-negative organisms; P1, period 1 (1979–1992), n = 120 episodes; P2, period 2 (1993–2003), n = 125 episodes; P3, period 3 (2004–2014), n = 242 episodes; all variables are expressed as percentage.
Table 4.
In Vitro Susceptibility Rates of different pathogens to empiric initial intraperitoneal therapies in period 1 (1979–1992).
Table 5.
In Vitro Susceptibility Rates of different pathogens to empiric initial intraperitoneal therapies in period 2 (1993–2003).
Table 6.
In Vitro Susceptibility Rates of different pathogens to empiric initial intraperitoneal therapies in period 3 (2004–2014).